All analyses were conducted using Statistica 13.3 software (StatSoft, Krakw, Poland)
Respecto a la funcin renal, la mayora de los agonistas GLP-1 no requieren ajuste de dosis en insuficiencia renal, aunque exenatide y lixisenatide tienen limitaciones en enfermedad renal crnica avanzada
First-line and advanced treatments, topical steroids and vitamin D analogs, phototherapy, and IL-17/IL-23 biologics, have strong evidence that peptides cannot match
Revised medical guidelines: If you need help navigating our provider portals, please see our videos, quick guides, and frequently asked questions (FAQ) pages: If you still have questions or need additional support, please contact Provider Customer Service: EmblemHealth: Commercial plans: 866-447-9717
personal communication